Eli Lilly shares slide premarket on news of failed trial for sarcoma treatment

France Nouvelles Nouvelles

Eli Lilly shares slide premarket on news of failed trial for sarcoma treatment
France Dernières Nouvelles,France Actualités
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

MarketWatch /  🏆 3. in US

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Lilly eyes more cancer deals, but wary of CAR-T, gene therapyLilly eyes more cancer deals, but wary of CAR-T, gene therapyEli Lilly and Co remains in the hunt for cancer drugs even after announcing an $...
Lire la suite »

Stocks making the biggest moves premarket: Tesla, CVS Health, Eli Lilly, Netflix & moreStocks making the biggest moves premarket: Tesla, CVS Health, Eli Lilly, Netflix & moreSome of the names on the move ahead of the open.
Lire la suite »

Lilly's cancer therapy Lartruvo fails study, shares dropLilly's cancer therapy Lartruvo fails study, shares dropEli Lilly and Co said on Friday its cancer treatment Lartruvo, approved on an ac...
Lire la suite »

Stocks making the biggest moves midday: Netflix, Boeing, Tesla, Eli Lilly & moreStocks making the biggest moves midday: Netflix, Boeing, Tesla, Eli Lilly & moreCheck out the companies making headlines midday Friday.
Lire la suite »

Lilly cancer drug fails key trial, will no longer be prescribedLilly cancer drug fails key trial, will no longer be prescribedEli Lilly and Co said on Friday that its cancer treatment Lartruvo, which had wo...
Lire la suite »

Eli Lilly’s Sarcoma Drug Combo Proves Ineffective in TrialsEli Lilly’s Sarcoma Drug Combo Proves Ineffective in TrialsEli Lilly said it would stop promoting Lartruvo, a relatively new cancer drug, after a study found it didn’t significantly prolong the lives of patients when used in combination with an older drug.
Lire la suite »

House Democrats launch drug-pricing probe into a dozen major health-care companiesHouse Democrats launch drug-pricing probe into a dozen major health-care companiesAbbVie, Amgen, AstraZeneca, Celgene, Eli Lilly, Johnson & Johnson, Mallinckrodt, Novartis, Novo Nordisk, Pfizer, Sanofi and Teva Pharmaceuticals received letters seeking detailed information and documents about the companies' pricing practices.
Lire la suite »

The inside story of Eli Lilly's 18-day race to secure an $8 billion deal for a drugmaker that's pioneering a new treatment for cancerThe inside story of Eli Lilly's 18-day race to secure an $8 billion deal for a drugmaker that's pioneering a new treatment for cancerEli Lilly's $8 billion bid for Loxo Oncology was negotiated during the 2018 holiday season, so as to make a big splash at a major industry conference.
Lire la suite »



Render Time: 2025-04-08 05:24:36